These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 18508885

  • 1. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.
    Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S.
    J Virol; 2008 Aug; 82(15):7677-87. PubMed ID: 18508885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of DC-SIGN in Lassa virus entry into human dendritic cells.
    Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S.
    J Virol; 2013 Nov; 87(21):11504-15. PubMed ID: 23966408
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell entry by human pathogenic arenaviruses.
    Rojek JM, Kunz S.
    Cell Microbiol; 2008 Apr; 10(4):828-35. PubMed ID: 18182084
    [Abstract] [Full Text] [Related]

  • 7. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
    Botten J, Whitton JL, Barrowman P, Sidney J, Whitmire JK, Alexander J, Kotturi MF, Sette A, Buchmeier MJ.
    J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.
    Sommerstein R, Ramos da Palma J, Olschläger S, Bergthaler A, Barba L, Lee BP, Pasquato A, Flatz L.
    J Virol; 2014 Aug; 88(15):8340-8. PubMed ID: 24829355
    [Abstract] [Full Text] [Related]

  • 13. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
    Takenaga T, Zhang Z, Muramoto Y, Fehling SK, Hirabayashi A, Takamatsu Y, Kajikawa J, Miyamoto S, Nakano M, Urata S, Groseth A, Strecker T, Noda T.
    Viruses; 2021 Sep 03; 13(9):. PubMed ID: 34578344
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
    Hashizume M, Takashima A, Iwasaki M.
    J Virol; 2024 Jun 13; 98(6):e0057824. PubMed ID: 38767352
    [Abstract] [Full Text] [Related]

  • 19. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
    Mateer EJ, Maruyama J, Card GE, Paessler S, Huang C.
    J Virol; 2020 Apr 16; 94(9):. PubMed ID: 32051278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.